Clinical Trial Update: Bariatric Surgery Combined With GLP-1 Receptor Agonists Study [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial is evaluating the combination of bariatric surgery with GLP-1 receptor agonists for obesity, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• GLP-1 receptor agonists

Snippet

Sponsor: China-Japan Friendship Hospital | Conditions: Obesity | Phase 1, Phase 2 | Status: RECRUITING